Last week, Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnea, a condition in which breathing stops and starts repeatedly during sleep. The ...

The weight-loss drug Zepbound was linked to a reduction in obstructive sleep apnea (OSA), according to new research. Pharmaceutical manufacturer Eli Lilly on Wednesday said injections of its obesity ...

A healthy diet, regular exercise, and stress management — these are well-established factors that promote weight control. But emerging evidence suggests that sleep also plays a powerful role in ...

People with obesity who received the weight-loss drug Zepbound had fewer obstructive sleep apnea events, or episodes of stopped breathing during sleep. The research by drug maker Eli Lilly included ...

Long Islanders suffering from sleep apnea inundated the sleep center at St. Charles Hospital in Port Jefferson with phone calls earlier this year after the Food and Drug Administration approved ...

Sleep apnea is a condition that causes breathing to stop and start repeatedly while sleeping. It may occur up to 400 times per night, with each pause lasting 10 seconds or longer. There are two main ...

Lauren Pastrana is the co-anchor of CBS4 News weeknights at 5, 6, 7 and 11 p.m. She joined CBS Miami in April 2012 as a reporter. She is an Emmy-nominated, multimedia journalist with experience in ...

Continuous positive airway pressure (CPAP) is the standard treatment for treating obstructive sleep apnea (OSA), but clinicians should remember that weight loss is also an effective approach for ...

Weight loss pills and injections are often touted as miracle drugs. Research shows that they can help you lose weight, better help you manage type II diabetes, and even reduce your risk of heart ...